Kemena A - Search Results

1

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.

Gandhi V, Kemena A, Keating MJ, Plunkett W. Gandhi V, et al. Among authors: kemena a. Cancer Res. 1992 Feb 15;52(4):897-903. Cancer Res. 1992. PMID: 1737352

2

Inhibition of fludarabine metabolism by arabinosylcytosine during therapy.

Kemena A, Gandhi V, Shewach DS, Keating M, Plunkett W. Kemena A, et al. Cancer Chemother Pharmacol. 1992;31(3):193-9. doi: 10.1007/BF00685547. Cancer Chemother Pharmacol. 1992. PMID: 1464155 Free article.

3

A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluids.

Kemena A, Fernandez M, Bauman J, Keating M, Plunkett W. Kemena A, et al. Clin Chim Acta. 1991 Aug 30;200(2-3):95-106. doi: 10.1016/0009-8981(91)90081-m. Clin Chim Acta. 1991. PMID: 1723357

4

Fludarabine phosphate: a new active agent in hematologic malignancies.

Keating MJ, O'Brien S, Plunkett W, Robertson LE, Gandhi V, Estey E, Dimopoulos M, Cabanillas F, Kemena A, Kantarjian H. Keating MJ, et al. Among authors: kemena a. Semin Hematol. 1994 Jan;31(1):28-39. Semin Hematol. 1994. PMID: 7510070 Review. No abstract available.

5

Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose schedule.

Kemena A, O'Brien S, Kantarjian H, Robertson L, Koller C, Beran M, Estey E, Plunkett W, Lerner S, Keating MJ. Kemena A, et al. Leuk Lymphoma. 1993 Jun;10(3):187-93. doi: 10.3109/10428199309145882. Leuk Lymphoma. 1993. PMID: 8220117 Clinical Trial.

6

Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy.

Gandhi V, Kemena A, Keating MJ, Plunkett W. Gandhi V, et al. Among authors: kemena a. Leuk Lymphoma. 1993 May;10(1-2):49-56. doi: 10.3109/10428199309147356. Leuk Lymphoma. 1993. PMID: 8374523 Clinical Trial.

7

Investigations on metabolism, genotoxic effects and carcinogenicity of 2,2'-dichlorodiethylether.

Norpoth K, Heger M, Müller G, Mohtashamipur E, Kemena A, Witting C. Norpoth K, et al. Among authors: kemena a. J Cancer Res Clin Oncol. 1986;112(2):125-30. doi: 10.1007/BF00404394. J Cancer Res Clin Oncol. 1986. PMID: 3771621

8

Investigations on metabolism and carcinogenicity of 1,1,2-trichloroethane.

Norpoth K, Heger M, Müller G, Mohtashamipur E, Kemena A, Witting C. Norpoth K, et al. Among authors: kemena a. J Cancer Res Clin Oncol. 1988;114(2):158-62. doi: 10.1007/BF00417830. J Cancer Res Clin Oncol. 1988. PMID: 3350848

9

The influence of 18 environmentally relevant polycyclic aromatic hydrocarbons and Clophen A50, as liver monooxygenase inducers, on the mutagenic activity of benz[a]anthracene in the Ames test.

Norpoth K, Kemena A, Jacob J, Schümann C. Norpoth K, et al. Among authors: kemena a. Carcinogenesis. 1984 Jun;5(6):747-52. doi: 10.1093/carcin/5.6.747. Carcinogenesis. 1984. PMID: 6426814

10

Evaluation of environmental carcinogens by carcinogen-specific test systems.

Grimmer G, Abel U, Brune H, Deutsch-Wenzel R, Emura M, Heinrich U, Jacob J, Kemena A, Misfeld J, Mohr U, et al. Grimmer G, et al. Among authors: kemena a. Exp Pathol. 1986;29(2):65-76. doi: 10.1016/s0232-1513(86)80036-6. Exp Pathol. 1986. PMID: 3709757 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters